Patent ID: 7144900
Filing Date: 2006-12-05
Classification: A61K,A61P,Y10S

Abstract:
1. A pharmaceutical composition comprising an insulin sensitivity enhancer in combination with a statin compound, wherein the insulin sensitivity enhancer is a compound represented by the formula: wherein R represents an optionally substituted hydrocarbon or 5- to 7-membered heterocyclic group; Y represents a group represented by —CO—, —CH(OH)— or —NR m is 0 or 1; n is 0, 1 or 2; X represents CH or N; A represents a bond or a C Q represents oxygen atom or sulfur atom; R ring E may optionally have further 1 to 4 substituents, and the substituents may optionally be combined with R L and M respectively represent hydrogen atom, or L and M may optionally be combined with each other to form a bond; or a pharmacologically acceptable salt thereof.